Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 19

Gastro Hep Advances A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseVolume 3, Issue 4P498-5052024This study explored the use of machine learning (ML) models to predict the risk of hepatocellular carcinoma (HCC) in patients suffering from metabolic dysfunction-associated steatotic liver disease (MASLD), a condition linked to rising HCC incidence, even in earlier stages. Researchers utilized clinical and laboratory data to train and validate a model across two distinct patient cohorts, finding that the Fibrosis-4 score, a noninvasive measure of liver fibrosis, was the most influential individual predictor. The resulting ML model demonstrated high predictive accuracy, achieving over 92% accuracy in the validation group, suggesting it is a powerful tool. Ultimately, this approach aims to offer physicians an early and personalized risk assessment for HCC in MASLD patients, potentially leading to more cost-effective screening and management